My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 267

    1.

    Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity.

    Stulnig TM, Oppermann U, Steffensen KR, Schuster GU, Gustafsson JA.

    Diabetes. 2002 Aug;51(8):2426-33.PMID: 12145154 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.

    Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD, Thieringer R.

    J Biol Chem. 2001 Apr 20;276(16):12629-35. Epub 2001 Jan 22.PMID: 11278270 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated.

    Napolitano A, Voice MW, Edwards CR, Seckl JR, Chapman KE.

    J Steroid Biochem Mol Biol. 1998 Mar;64(5-6):251-60.PMID: 9618026 [PubMed - indexed for MEDLINE]Related articles

    4.

    Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.

    Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS.

    J Biol Chem. 2002 Mar 15;277(11):9520-8. Epub 2002 Jan 8.PMID: 11782483 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.

    Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, Collins JL, Osborne TF, Tontonoz P.

    J Biol Chem. 2002 Mar 29;277(13):11019-25. Epub 2002 Jan 14.PMID: 11790787 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    On the role of liver X receptors in lipid accumulation in adipocytes.

    Juvet LK, Andresen SM, Schuster GU, Dalen KT, Tobin KA, Hollung K, Haugen F, Jacinto S, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI.

    Mol Endocrinol. 2003 Feb;17(2):172-82.PMID: 12554745 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.

    Hermanowski-Vosatka A, Gerhold D, Mundt SS, Loving VA, Lu M, Chen Y, Elbrecht A, Wu M, Doebber T, Kelly L, Milot D, Guo Q, Wang PR, Ippolito M, Chao YS, Wright SD, Thieringer R.

    Biochem Biophys Res Commun. 2000 Dec 20;279(2):330-6.PMID: 11118287 [PubMed - indexed for MEDLINE]Related articles

    8.

    Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice.

    Morton NM, Holmes MC, Fiévet C, Staels B, Tailleux A, Mullins JJ, Seckl JR.

    J Biol Chem. 2001 Nov 2;276(44):41293-300. Epub 2001 Aug 23.PMID: 11546766 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice.

    Liu Y, Yan C, Wang Y, Nakagawa Y, Nerio N, Anghel A, Lutfy K, Friedman TC.

    Endocrinology. 2006 Nov;147(11):5061-8. Epub 2006 Jul 27.PMID: 16873540 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Ontogeny and sexual dimorphic expression of mouse type 2 11beta-hydroxysteroid dehydrogenase.

    Condon J, Ricketts ML, Whorwood CB, Stewart PM.

    Mol Cell Endocrinol. 1997 Mar 28;127(2):121-8.PMID: 9099907 [PubMed - indexed for MEDLINE]Related articles

    11.

    Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines.

    Bland R, Worker CA, Noble BS, Eyre LJ, Bujalska IJ, Sheppard MC, Stewart PM, Hewison M.

    J Endocrinol. 1999 Jun;161(3):455-64.PMID: 10333548 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.

    Ide T, Shimano H, Yoshikawa T, Yahagi N, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Yatoh S, Iizuka Y, Tomita S, Ohashi K, Takahashi A, Sone H, Gotoda T, Osuga J, Ishibashi S, Yamada N.

    Mol Endocrinol. 2003 Jul;17(7):1255-67. Epub 2003 May 1.PMID: 12730332 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Expression of 11beta-hydroxysteroid dehydrogenase type 2 in an ACTH-producing small cell lung cancer.

    Parks LL, Turney MK, Gaitan D, Kovacs WJ.

    J Steroid Biochem Mol Biol. 1998 Nov;67(4):341-6.PMID: 9883991 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels.

    Kim J, Temple KA, Jones SA, Meredith KN, Basko JL, Brady MJ.

    J Biol Chem. 2007 Apr 13;282(15):11038-46. Epub 2007 Feb 20.PMID: 17311922 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.

    Wamil M, Andrew R, Chapman KE, Street J, Morton NM, Seckl JR.

    Endocrinology. 2008 Dec;149(12):5909-18. Epub 2008 Aug 28.PMID: 18755798 [PubMed - indexed for MEDLINE]Related articles

    16.

    Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1.

    Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR.

    J Endocrinol. 1999 Jan;160(1):103-9.PMID: 9854182 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line.

    Darnel AD, Archer TK, Yang K.

    J Steroid Biochem Mol Biol. 1999 Sep-Oct;70(4-6):203-10.PMID: 10622409 [PubMed - indexed for MEDLINE]Related articles

    18.

    Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice.

    Alberts P, Engblom L, Edling N, Forsgren M, Klingström G, Larsson C, Rönquist-Nii Y, Ohman B, Abrahmsén L.

    Diabetologia. 2002 Nov;45(11):1528-32. Epub 2002 Sep 18.PMID: 12436336 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.

    Ulven SM, Dalen KT, Gustafsson JA, Nebb HI.

    J Lipid Res. 2004 Nov;45(11):2052-62. Epub 2004 Aug 1.PMID: 15292368 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.

    Nakano S, Inada Y, Masuzaki H, Tanaka T, Yasue S, Ishii T, Arai N, Ebihara K, Hosoda K, Maruyama K, Yamazaki Y, Shibata N, Nakao K.

    Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1213-22. Epub 2006 Dec 26.PMID: 17190905 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity